IP licensing and business: June 5-18
By Steve Scherer ( June 18, 2026, 19:56 GMT | Insight) -- LinkConnect launched with a large telecom network patent portfolio, Everest Medicines struck a major drug licensing deal with Dimerix and Applied Atomics secured rights to commercialize BWXT's small modular reactor technology. Other licensing activity in the US and abroad over the last two weeks included Nokia's expansion of its licensing reach through new patent agreements, and Avanci and Sisvel's reporting of growth in their automotive and payment-terminal patent pools.LinkConnect launched with a portfolio of more than 1,000 former Nokia and Alcatel-Lucent patent assets, Everest Medicines agreed to a licensing agreement worth up to $340 million-plus royalties for Dimerix's kidney disease therapy in Asia-Pacific, and Applied Atomics secured exclusive rights to commercialize BWXT's mPower small modular reactor technology....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.